Multiple roles for tumor necrosis factor-α and lymphotoxin α/β in immunity and autoimmunity

[1]  K. Tamada,et al.  The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. , 2001, The Journal of clinical investigation.

[2]  Dianna Y. Wu,et al.  Tolerance to Cyclosporin A-Induced Autologous Graft-Versus-Host Disease Is Mediated by a CD4+CD25+ Subset of Recent Thymic Emigrants1 , 2001, The Journal of Immunology.

[3]  U. Chaudhari,et al.  Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial , 2001, The Lancet.

[4]  H. Mcdevitt,et al.  A Critical Role for Lymphotoxin-β Receptor in the Development of Diabetes in Nonobese Diabetic Mice , 2001, The Journal of Experimental Medicine.

[5]  J. Bluestone,et al.  Reversal of Spontaneous Autoimmune Insulitis in Nonobese Diabetic Mice by Soluble Lymphotoxin Receptor , 2001, The Journal of experimental medicine.

[6]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[7]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[8]  A. Cope,et al.  Prolonged Exposure of T Cells to TNF Down-Regulates TCRζ and Expression of the TCR/CD3 Complex at the Cell Surface1 , 2001, The Journal of Immunology.

[9]  George Kollias,et al.  Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level , 2001, The Journal of experimental medicine.

[10]  G. Shulman,et al.  Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. , 2001, The Journal of clinical investigation.

[11]  Steffen Jung,et al.  Regulation of Peripheral Lymph Node Genesis by the Tumor Necrosis Factor Family Member Trance , 2000, The Journal of experimental medicine.

[12]  Jason G. Cyster,et al.  A chemokine-driven positive feedback loop organizes lymphoid follicles , 2000, Nature.

[13]  G. Kollias,et al.  Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor , 2000, European journal of immunology.

[14]  A. Pierani,et al.  Requirement for RORgamma in thymocyte survival and lymphoid organ development. , 2000, Science.

[15]  S. Sakaguchi.  Regulatory T cells , 2000, Cell.

[16]  D. Hanahan,et al.  BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. , 2000, Immunity.

[17]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[18]  J. Sedgwick,et al.  Novel concepts of tumor necrosis factor action in autoimmune pathology. , 2000, Current directions in autoimmunity.

[19]  C. Fathman.  Biologic and Gene Therapy of Autoimmune Disease , 2000 .

[20]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[21]  J. Cyster,et al.  Chemokines and cell migration in secondary lymphoid organs. , 1999, Science.

[22]  G. Oliver,et al.  Prox1 Function Is Required for the Development of the Murine Lymphatic System , 1999, Cell.

[23]  J. Browning,et al.  The Requirement of Membrane Lymphotoxin for the Presence of Dendritic Cells in Lymphoid Tissues , 1999, The Journal of experimental medicine.

[24]  M. Feldmann,et al.  Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. , 1999, Journal of immunology.

[25]  Sakae Tanaka,et al.  Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[26]  S. Hanauer,et al.  Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. , 1999, Inflammatory bowel diseases.

[27]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.

[28]  K. Frei,et al.  Severity of symptoms and demyelination in MOG‐induced EAE depends on TNFR1 , 1999, European journal of immunology.

[29]  J. Cyster,et al.  Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen , 2022 .

[30]  K. Rajewsky,et al.  Mature Follicular Dendritic Cell Networks Depend on Expression of Lymphotoxin β Receptor by Radioresistant Stromal Cells and of Lymphotoxin β and Tumor Necrosis Factor by B Cells , 1999, The Journal of experimental medicine.

[31]  Samir A. Shah,et al.  Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. , 1998, Gastroenterology.

[32]  F. Mackay,et al.  The Sequential Role of Lymphotoxin and B Cells in the Development of Splenic Follicles , 1998, The Journal of experimental medicine.

[33]  P. Scheurich,et al.  The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Ware,et al.  TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. , 1998, Journal of immunology.

[35]  T. Kirchgessner,et al.  Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. , 1997, The Journal of clinical investigation.

[36]  P. Hjelmström,et al.  A Critical Role for Lymphotoxin in Experimental Allergic Encephalomyelitis , 1997, The Journal of experimental medicine.

[37]  I. Weissman,et al.  Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. , 1997, Immunity.

[38]  R. Locksley,et al.  Immunological Tolerance to a Pancreatic Antigen as a Result of Local Expression of TNFα by Islet β Cells , 1997 .

[39]  F. Mackay,et al.  Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice , 1997, European journal of immunology.

[40]  H. Mcdevitt,et al.  The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire , 1997 .

[41]  G. Kollias,et al.  Chronic Tumor Necrosis Factor Alters T Cell Responses by Attenuating T Cell Receptor Signaling , 1997, The Journal of experimental medicine.

[42]  E. Wolf,et al.  A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen , 1996, Cell.

[43]  F. Barkhof,et al.  Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2 , 1996, Neurology.

[44]  H. Mcdevitt,et al.  Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Mackay,et al.  Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs , 1996, The Journal of experimental medicine.

[46]  T. Mak,et al.  Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells , 1996, Immunology.

[47]  B. Spiegelman,et al.  IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.

[48]  M. Lenardo,et al.  Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.

[49]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[50]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[51]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[52]  D. Goeddel,et al.  Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75 , 1995, The Journal of experimental medicine.

[53]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[54]  B. Spiegelman,et al.  Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.

[55]  R. Tisch,et al.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.

[56]  A. Cooke,et al.  Studies on the thymus of non-obese diabetic (NOD) mice: effect of transgene expression. , 1994, Immunology.

[57]  B. Spiegelman,et al.  Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[59]  L. Tartaglia,et al.  Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. , 1993, Journal of immunology.

[60]  R. Flavell,et al.  Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. , 1993, Journal of immunology.

[61]  J. Bach,et al.  Characterization of the Extracellular Matrix—Containing Giant Perivascular Spaces in the NOD Mouse Thymus , 1993, Diabetes.

[62]  B. Nabarra,et al.  Thymus reticulum of autoimmune mice. 3. Ultrastructural study of NOD (non-obese diabetic) mouse thymus. , 1991, International journal of experimental pathology.

[63]  H. Mcdevitt,et al.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[64]  D. Wofsy,et al.  Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice , 1989 .

[65]  C. Jacob,et al.  Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis , 1988, Nature.

[66]  M. Feldmann,et al.  Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? , 2001, Annual review of immunology.

[67]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[68]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. , 1999, Nature genetics.

[69]  D. Chaplin,et al.  Development and maturation of secondary lymphoid tissues. , 1999, Annual review of immunology.

[70]  Y. Goltsev,et al.  Tumor necrosis factor receptor and Fas signaling mechanisms. , 1999, Annual review of immunology.

[71]  S. Michie,et al.  The roles of alpha 4-integrins in the development of insulin-dependent diabetes mellitus. , 1998, Current topics in microbiology and immunology.

[72]  S. Michie,et al.  The Roles of α4-Integrins in the Development of Insulin-Dependent Diabetes Mellitus , 1998 .

[73]  R. Locksley,et al.  Immunological tolerance to a pancreatic antigen as a result of local expression of TNFalpha by islet beta cells. , 1997, Immunity.

[74]  D. Cantrell,et al.  T cell antigen receptor signal transduction pathways. , 1996, Annual review of immunology.

[75]  C. Ware,et al.  The ligands and receptors of the lymphotoxin system. , 1995, Current topics in microbiology and immunology.

[76]  D. Wofsy,et al.  Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. , 1989, Clinical immunology and immunopathology.

[77]  H. Mcdevitt,et al.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. , 1988, Nature.

[78]  B. Nabarra,et al.  Thymic reticulum of autoimmune mice. I. Ultrastructural studies of the diabetic (db/db) mouse thymus. , 1986, Experimental pathology.